Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Income from Continuing Operations (2020 - 2026)

Journey Medical filings provide 6 years of Income from Continuing Operations readings, the most recent being 1247000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 178.82% to 1247000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 11431000.0, a 21.76% increase, with the full-year FY2025 number at 11431000.0, up 22.08% from a year prior.
  • Income from Continuing Operations hit 1247000.0 in Q4 2025 for Journey Medical, up from 2315000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 16789000.0 in Q3 2023 to a low of 21751000.0 in Q4 2021.
  • Median Income from Continuing Operations over the past 5 years was 3934500.0 (2025), compared with a mean of 5175850.0.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 36810.34% in 2021 and later skyrocketed 266.56% in 2023.
  • Journey Medical's Income from Continuing Operations stood at 21751000.0 in 2021, then skyrocketed by 51.07% to 10642000.0 in 2022, then soared by 79.86% to 2143000.0 in 2023, then soared by 173.82% to 1582000.0 in 2024, then tumbled by 178.82% to 1247000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 1247000.0 (Q4 2025), 2315000.0 (Q3 2025), and 3796000.0 (Q2 2025) per Business Quant data.